Skip to main content

Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results

WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2024. Fourth quarter financial summaryRevenues of $795.4 million, up 2.8% compared to the prior year period, up 3.2% on an adjusted constant currency basisGAAP diluted EPS from continuing operations of $(2.95), compared to $0.66 in the prior year periodAdjusted diluted EPS from continuing operations of $3.89, compared to $3.38 in the prior year periodFull year 2024 financial summaryGAAP revenue of $3,047.3 million, up 2.4% compared to the prior year periodAdjusted revenue of $3,061.1 million, excluding the impact from increases in our reserves related to the Italian payback measure pertaining to prior years, up 2.9% compared to the prior year period,...

Continue reading

Playtika Holding Corp. Reports Q4 and 2024 Financial Results

Revenue of $650.3 million and Direct-to-Consumer (“DTC”) Revenue of $174.6 millionDTC platforms Revenue Increased 0.1% Sequentially and 8.0% Year Over YearGAAP Net Income of $(16.7) million and Credit Adj. EBITDA of $183.9 million HERZLIYA, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) — Playtika Holding Corp. (NASDAQ: PLTK) today released financial results for its fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights:Revenue of $650.3 million increased 4.8% sequentially and 1.9% year over year. DTC platforms revenue of $174.6 million increased 0.1% sequentially and 8.0% year over year. Net income of $(16.7) million decreased (142.5)% sequentially and (144.8)% year over year. Credit Adjusted EBITDA of $183.9 million decreased (6.7)% sequentially and (2.6)% year over year. Cash and cash equivalents...

Continue reading

Landsea Homes Reports Fourth Quarter and Full Year 2024 Results

Record fourth quarter home sales revenue of $450.6 million Record fourth quarter home closings of 937, up 41% Record full year total revenue of $1.55 billion Fourth quarter net new home orders of 636, up 60% Fourth quarter cash from operations of $47.8 million Fourth quarter net income of $3.0 million, or $0.08 per diluted share Full year net income of $17.2 million or $0.47 per diluted share Year-end book value per share of $18.37DALLAS, Feb. 27, 2025 (GLOBE NEWSWIRE) — Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”) announced today financial results for the fourth quarter and full year ended December 31, 2024. For the quarter, the Company reported pretax income of $6.5 million and net income of $3.0 million, or $0.08 per diluted share. Adjusted net income (a non-GAAP measure) was $9.1 million or...

Continue reading

LifeStance Reports Fourth Quarter and Full Year 2024 Results

SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted)2024 Highlights and 2025 OutlookFourth quarter revenue of $325.5 million increased 16% and full year revenue of $1,251.0 million increased 19% compared to revenue of $1,055.7 million Clinician base increased 12% to 7,424 clinicians, a sequential net increase of 155 in the fourth quarter and 779 for the full year Fourth quarter visit volumes increased 14% to 2.0 million and full year visit volumes increased 15% to 7.9 million Net loss of $7.1 million in the fourth quarter and $57.4 million...

Continue reading

Millicom (Tigo) Q4 2024 Earnings Release

Millicom (Tigo) Q4 2024 Earnings Release Luxembourg, February 27, 2025 – Millicom is pleased to announce its fourth quarter 2024 results. Please find below links to the Q4 2024 Earnings Release and IAS 34 Interim Condensed Consolidated Financial Statements. Q4 Highlights*Revenue $1.43 billionOperating profit $373 million, and EBITDA $618 millionNet income of $31 millionEquity free cash flow $236 million, leading to year-end leverage of 2.42xRobust commercial activity continued in Q4: 274,000 Postpaid Mobile and 49,000 Home FTTH/HFC net additionsFull Year Highlights*Revenue $5.80 billion, up 2.5% year-on-yearOperating profit $1.34, up 62.5% Net income of $253 million or $1.47 per shareEBITDA $2.47 billion up 16.9% (15.8% organically)Equity free cash flow $777 million ($728 million excluding disposals) 965,000...

Continue reading

Gray Media’s Fourth Quarter Financial Results Exceeded Expectations

ATLANTA, Feb. 27, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray,” “Gray Media,” “we,” “us” or “our”) (NYSE: GTN) today announced its financial results for the quarter ended December 31, 2024, which included revenues and expenses both finishing slightly better than guidance. For the full-year 2024, our portfolio of leading television stations earned $497 million of political advertising revenue, which we estimate to be the highest level of political advertising revenue among our peers, in total and on a per television household basis. Total operating expenses (before depreciation, amortization and loss on disposal of assets) in the fourth quarter of 2024 were $648 million, which was 2% below the low end of our previously announced guidance for the quarter. In addition, during 2024, we reduced the outstanding principal amount of...

Continue reading

Crawford United Corporation Announces Fourth Quarter and Full Year 2024 Results

Earnings per share of $3.83 for the year and $1.11 for the quarter Sales of $150.2 million for the year, an increase of 4.4% Net income of $13.6 million for the year, an increase of 2.3% EBITDA As Defined1 of $26.5 million for the year, an increase of 3.8%CLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) — Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the quarter and year ended December 31, 2024. For the quarter ended December 31, 2024, sales were $37.4 million compared with $33.8 million in the same period in 2023, an increase of 10.5%. In the quarter, the Company recorded operating income of $4.7 million compared with operating income of $3.4 million in the same period of the prior year, an increase of 41.0%. Net income was $3.9 million, or $1.11 per...

Continue reading

Enerflex Ltd. Announces Fourth Quarter 2024 Financial and Operational Results

ADJUSTED EBITDA OF $121 MILLION AND FREE CASH FLOW OF $76 MILLION1 EI CONTRACT BACKLOG AND ES BACKLOG OF $1.5 BILLION AND $1.3 BILLION, RESPECTIVELY, PROVIDING STRONG OPERATIONAL VISIBILITY REDUCED BANK ADJUSTED NET DEBT-TO-EBITDA RATIO2 TO 1.5X TIMES AT YEAR-END CALGARY, Alberta, Feb. 27, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today reported its financial and operational results for the three and twelve months ended December 31, 2024. All amounts presented are in U.S. Dollars (“USD”) unless otherwise stated. Q4/24 FINANCIAL AND OPERATIONAL OVERVIEW         Generated revenue of $561 million compared to $574 million in Q4/23 and $601 million in Q3/24. Recorded gross margin before depreciation and amortization of $174 million, or 31% of revenue, compared to $158 million, or...

Continue reading

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers with ~55% of Tier 1 HCPs prescribing Ohtuvayre through February 2025 Phase 2 programs in bronchiectasis and fixed-dose combination in COPD advance Conference call today at 9:00 a.m. EST / 2:00 p.m. GMT LONDON and RALEIGH, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces its financial results for the fourth quarter and full year ended December 31, 2024, and provides a corporate update. “2024 was another transformational year for Verona Pharma with the US approval and launch of Ohtuvayre (ensifentrine), the first...

Continue reading

Ducommun Incorporated Reports Fourth Quarter 2024 Results

Solid Finish to 2024; Record Full Year Revenue and Gross Margins SANTA ANA, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today reported results for its fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 RecapNet revenue of $197.3 million, an increase of 2.6% over Q4 2023 Gross margin of 23.5% showed year-over-year growth of 180 bps Net income of $6.8 million increased 33% year-over-year, or $0.45 per diluted share, or 3.4% of revenue, up 70 bps year-over-year Non-GAAP adjusted net income for the quarter of $11.4 million which increased 9% year-over-year, or $0.75 per diluted share Adjusted EBITDA of $27.3 million (increase of 19% year-over-year), or 13.8% of revenue, up 180 bps year-over-year“We made excellent progress in our VISION 2027 commitments...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.